Reference answer · compliance-guide · reviewed quarterly
Last updated
Review cadence: quarterlyUnderlying federal data: refreshed weekly to annual per source
Q&A library · compliance-guide

How can home infusion pharmacies ensure 340B compliance during HRSA 2026 audits?

Home infusion pharmacies can strengthen 340B compliance by maintaining strict inventory segregation, verifying prescription origination, and confirming patient eligibility. HRSA’s 2026 audits emphasize tracing each vial’s movement, validating provider relationships, and ensuring all documentation connects to the covered entity’s scope of care to prevent diversion and disallowed purchases.

Related questions.

Q&A librarySourced · reviewed quarterly
compliance-guideHow can oncology infusion centers prepare for HRSA 2026 340B audits?compliance-guideWhat are HRSA’s 2026 audit priorities for FQHC 340B compliance?compliance-guideHow can FQHCs meet HRSA 2026 audit requirements for 340B compliance?compliance-guideHow should hospitals prepare for HRSA 2026 340B audits on eligibility and replenishment?compliance-guideHow can covered entities ensure 340B split-billing compliance for HRSA 2026 audits?compliance-guideHow should hospital outpatient departments prepare for 2026 HRSA 340B audits?
Browse all canonical questions →